0 CHECKOUT

Summary: Merrill Lynch Puttable FLOATs/RITES Trust Series PT-1000 Lansing Board of Water & Light, Michigan; Residual Certificates; Tender Option Certificates/Bonds Jun 11

  • ID: 1828350
  • June 2011
  • Region: Michigan
  • Standard & Poors

FEATURED COMPANIES

  • Lansing Brd of Wtr & Lt
  • MORE

Abstract
Standard & Poor's Ratings Services assigned its 'AA-/A-1' rating to Merrill Lynch P-FLOATS series PT-1000 Trust ,puttable floating option tax-exempt receipts, series PT-4700, relating to Lansing Board of Water and Light, Mich., utility system revenue bonds, series 2011A. The long-term component of the rating is based on the 'AA-' rated, underlying bond. The short-term rating is based on the liquidity facility by MLIB with a guarantee from Merrill Lynch & Co. The expiration date of the liquidity facility is Jan. 15, 2012. Standard & Poor's assigned its 'AA-' rating to Merrill Lynch Puttable FLOATs/RITEs Trust, residual interest tax-exempt securities receipts, series PT-4700, relating to Lansing Board of Water and Light utility system revenue bonds, series 2011A. The long-term component of...

Companies mentioned in this report are:
- Lansing Brd of Wtr & Lt
- Merrill Lynch Put FLOATs/RITES tr ser PT-1000

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress READ MORE >

Note: Product cover images may vary from those shown

- Lansing Brd of Wtr & Lt
- Merrill Lynch Put FLOATs/RITES tr ser PT-1000

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.